Nicholas Chan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nicholas Chan has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
- Tom Kai Ming Wang
Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA
5 shared publications - Anish Krishnan
Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
4 shared publications - Bo Xu
Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA
3 shared publications - Brian Griffin
Cleveland Clinic
3 shared publications - John James Atherton
Royal Brisbane and Women's Hospital
3 shared publications Richard A. Grimm
Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute Cleveland Clinic Cleveland OH
3 shared publications
Latest Publications
- 23 November 2024
- Published by Elsevier in The American Journal of Cardiology
- Vol. 237, 60-64
The Impact of Active Ascertainment on Sex-Specific Differences in the Prevalence and Phenotype of Transthyretin Cardiac Amyloidosis: The Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations Study
- 23 November 2024
- Published by Elsevier in The American Journal of Cardiology
- Vol. 237, 60-64
The Impact of Active Ascertainment on Sex-Specific Differences in the Prevalence and Phenotype of Transthyretin Cardiac Amyloidosis: The Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations Study
- 6 March 2024
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 30 (9) , 1100-1107
Temporal Outcomes of Patients Diagnosed With Transthyretin Cardiac Amyloidosis
- 6 March 2024
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 30 (9) , 1100-1107
Temporal Outcomes of Patients Diagnosed With Transthyretin Cardiac Amyloidosis
- Open Access
- 2 January 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (1) , e031505
Impact of Bariatric Surgery on Left Ventricular Structure and Function
Background: Obesity leads to an increased risk of cardiovascular disease morbidity and death, including heart failure. Bariatric surgery has been proven to be the most effective long‐term weight management treatment. This study investigated the changes in cardiac structure and function after bariatric surgery, including left ventricular global longitudinal strain. Methods and Results: There were 398 consecutive patients who underwent bariatric surgery with pre‐ and postoperative transthoracic echocardiographic imaging at a US health system between 2004 and 2019. We compared cardiovascular risk factors and echocardiographic parameters between baseline and follow‐up at least 6 months postoperatively. Along with decreases in weight postoperatively, there were significant improvements in cardiovascular risk factors, including reduction in systolic blood pressure levels from 132 mm Hg (25th–75th percentile: 120–148 mm Hg) to 127 mm Hg (115–140 mm Hg; P =0.003), glycated hemoglobin levels from 6.5% (5.9%–7.6%) to 5.7% (5.4%–6.3%; P P P P P <0.001) postoperatively. Conclusions: This study has shown the long‐term impact of bariatric surgery on cardiac structure and function, with reductions in left ventricular mass and improvement in left ventricular global longitudinal strain. These findings support the cardiovascular benefits of bariatric surgery.
- 2 January 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (1) , e031505
Open AccessImpact of Bariatric Surgery on Left Ventricular Structure and Function
Background: Obesity leads to an increased risk of cardiovascular disease morbidity and death, including heart failure. Bariatric surgery has been proven to be the most effective long‐term weight management treatment. This study investigated the changes in cardiac structure and function after bariatric surgery, including left ventricular global longitudinal strain. Methods and Results: There were 398 consecutive patients who underwent bariatric surgery with pre‐ and postoperative transthoracic echocardiographic imaging at a US health system between 2004 and 2019. We compared cardiovascular risk factors and echocardiographic parameters between baseline and follow‐up at least 6 months postoperatively. Along with decreases in weight postoperatively, there were significant improvements in cardiovascular risk factors, including reduction in systolic blood pressure levels from 132 mm Hg (25th–75th percentile: 120–148 mm Hg) to 127 mm Hg (115–140 mm Hg; P =0.003), glycated hemoglobin levels from 6.5% (5.9%–7.6%) to 5.7% (5.4%–6.3%; P P P P P <0.001) postoperatively. Conclusions: This study has shown the long‐term impact of bariatric surgery on cardiac structure and function, with reductions in left ventricular mass and improvement in left ventricular global longitudinal strain. These findings support the cardiovascular benefits of bariatric surgery.
- 1 August 2023
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 16 (8) , 607-616
Prognostic Power of Quantitative Assessment of Functional Mitral Regurgitation and Myocardial Scar Quantification by Cardiac Magnetic Resonance
BACKGROUND: The severity classification of functional mitral regurgitation (FMR) remains controversial despite adverse prognosis and rapidly evolving interventions. Furthermore, it is unclear if quantitative assessment with cardiac magnetic resonance can provide incremental risk stratification for patients with ischemic cardiomyopathy (ICM) or non-ICM (NICM) in terms of FMR and late gadolinium enhancement (LGE). We evaluated the impact of quantitative cardiac magnetic resonance parameters on event-free survival separately for ICM and NICM, to assess prognostic FMR thresholds and interactions with LGE quantification. METHODS: Patients (n=1414) undergoing cardiac magnetic resonance for cardiomyopathy (ejection fractionP =0.034) in ICM and 1.09 (1.02–1.16; P =0.011) in NICM. Optimal mitral regurgitation-fraction threshold for moderate and severe FMR were ≥20% and ≥35%, respectively, in both ICM and NICM, based on the prediction of the primary outcome. Similarly, optimal LGE thresholds were ≥5% in ICM and ≥2% in NICM. Mitral regurgitation-fraction×LGE emerged as a significant interaction for the primary end point in ICM ( P =0.006), but not in NICM ( P =0.971). CONCLUSIONS: Mitral regurgitation-fraction and LGE are key quantitative cardiac magnetic resonance biomarkers with differential associations with adverse outcomes in ICM and NICM. Optimal prognostic thresholds may provide important clinical risk prognostication and may further facilitate the ability to derive selection criteria to guide therapeutic decision-making.
- 1 August 2023
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 16 (8) , 607-616
Prognostic Power of Quantitative Assessment of Functional Mitral Regurgitation and Myocardial Scar Quantification by Cardiac Magnetic Resonance
BACKGROUND: The severity classification of functional mitral regurgitation (FMR) remains controversial despite adverse prognosis and rapidly evolving interventions. Furthermore, it is unclear if quantitative assessment with cardiac magnetic resonance can provide incremental risk stratification for patients with ischemic cardiomyopathy (ICM) or non-ICM (NICM) in terms of FMR and late gadolinium enhancement (LGE). We evaluated the impact of quantitative cardiac magnetic resonance parameters on event-free survival separately for ICM and NICM, to assess prognostic FMR thresholds and interactions with LGE quantification. METHODS: Patients (n=1414) undergoing cardiac magnetic resonance for cardiomyopathy (ejection fractionP =0.034) in ICM and 1.09 (1.02–1.16; P =0.011) in NICM. Optimal mitral regurgitation-fraction threshold for moderate and severe FMR were ≥20% and ≥35%, respectively, in both ICM and NICM, based on the prediction of the primary outcome. Similarly, optimal LGE thresholds were ≥5% in ICM and ≥2% in NICM. Mitral regurgitation-fraction×LGE emerged as a significant interaction for the primary end point in ICM ( P =0.006), but not in NICM ( P =0.971). CONCLUSIONS: Mitral regurgitation-fraction and LGE are key quantitative cardiac magnetic resonance biomarkers with differential associations with adverse outcomes in ICM and NICM. Optimal prognostic thresholds may provide important clinical risk prognostication and may further facilitate the ability to derive selection criteria to guide therapeutic decision-making.
- Open Access
- 29 July 2023
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 32, S217
Sudden Cardiac Death in a Contemporary Cohort With Myocardial Infarction: Defining Prevalence and Left Ventricular Ejection Fraction on Early Echocardiography
- 29 July 2023
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 32, S217
Open AccessSudden Cardiac Death in a Contemporary Cohort With Myocardial Infarction: Defining Prevalence and Left Ventricular Ejection Fraction on Early Echocardiography
- 29 July 2023
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 32, S150
Constrictive Pericarditis Following mRNA COVID-19 Vaccination Requiring Treatment With Biological Disease-Modifying Anti-Rheumatic Drugs
- 29 July 2023
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 32, S150
Constrictive Pericarditis Following mRNA COVID-19 Vaccination Requiring Treatment With Biological Disease-Modifying Anti-Rheumatic Drugs
- Open Access
- 29 July 2023
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 32, S230
Clinical Utility of Echocardiography in Non-ST-Elevation Myocardial Infarction: Validation of Guideline-Recommended Approaches
- 29 July 2023
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 32, S230
Open AccessClinical Utility of Echocardiography in Non-ST-Elevation Myocardial Infarction: Validation of Guideline-Recommended Approaches
- Open Access
- 29 July 2023
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 32, S308-S309
Survivorship Following Myocardial Infarction in a Contemporary Australian Cohort: Defining the Relative Contributions of Cardiac and Non-Cardiac Mortality to Long-Term Outcomes
- 29 July 2023
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 32, S308-S309
Open AccessSurvivorship Following Myocardial Infarction in a Contemporary Australian Cohort: Defining the Relative Contributions of Cardiac and Non-Cardiac Mortality to Long-Term Outcomes
- 8 July 2023
- Published by Elsevier in The American Journal of Cardiology
- Vol. 202, 131-143
Echocardiographic Evaluation of Diastolic Function in Special Populations
- 8 July 2023
- Published by Elsevier in The American Journal of Cardiology
- Vol. 202, 131-143
Echocardiographic Evaluation of Diastolic Function in Special Populations
- Open Access
Contemporary Review of Transcatheter Mitral Valve Interventions for Mitral Regurgitation
Mitral regurgitation (MR) is the most common form of valvular heart disease in the United States, and there are established guidelines for indications for requiring mitral valve surgeries. However, there is an unmet clinical need for a subset of high-risk MR patients, especially those with advanced age, heart failure and/or secondary MR. Following the successes of transcatheter aortic valve replacements, significant advances have occurred over the last decade in transcatheter mitral valve interventions in order to manage these patients in both clinical practice and trials. The three main types of these interventions include a transcatheter edge-to-edge repair, percutaneous mitral annuloplasty (both direct and indirect) and transcatheter mitral valve replacement (including when applied to a prior prosthetic valve, annuloplasty ring and mitral annuloplasty ring). This review aims to discuss the contemporary techniques, evidence, indications, multimodality imaging evaluations and outcomes of the various transcatheter mitral valve interventions.
Open AccessContemporary Review of Transcatheter Mitral Valve Interventions for Mitral Regurgitation
Mitral regurgitation (MR) is the most common form of valvular heart disease in the United States, and there are established guidelines for indications for requiring mitral valve surgeries. However, there is an unmet clinical need for a subset of high-risk MR patients, especially those with advanced age, heart failure and/or secondary MR. Following the successes of transcatheter aortic valve replacements, significant advances have occurred over the last decade in transcatheter mitral valve interventions in order to manage these patients in both clinical practice and trials. The three main types of these interventions include a transcatheter edge-to-edge repair, percutaneous mitral annuloplasty (both direct and indirect) and transcatheter mitral valve replacement (including when applied to a prior prosthetic valve, annuloplasty ring and mitral annuloplasty ring). This review aims to discuss the contemporary techniques, evidence, indications, multimodality imaging evaluations and outcomes of the various transcatheter mitral valve interventions.